These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22239431)

  • 1. Improving radioresponse through modification of the tumor immunological microenvironment.
    Chi KH; Wang YS; Kao SJ
    Cancer Biother Radiopharm; 2012 Feb; 27(1):6-11. PubMed ID: 22239431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response regulation in the tumor microenvironment by hypoxia.
    Labiano S; Palazon A; Melero I
    Semin Oncol; 2015 Jun; 42(3):378-86. PubMed ID: 25965356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.
    Tamura R; Tanaka T; Akasaki Y; Murayama Y; Yoshida K; Sasaki H
    Med Oncol; 2019 Nov; 37(1):2. PubMed ID: 31713115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
    Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
    Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK Cell Metabolism and Tumor Microenvironment.
    Terrén I; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
    Front Immunol; 2019; 10():2278. PubMed ID: 31616440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T cells - stroma interactions.
    Noman MZ; Benlalam H; Hasmim M; Chouaib S
    Bull Cancer; 2011 Feb; 98(2):E19-24. PubMed ID: 21339092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXOs in cancer immunity: Knowns and unknowns.
    Deng Y; Wang F; Hughes T; Yu J
    Semin Cancer Biol; 2018 Jun; 50():53-64. PubMed ID: 29309928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy and radiation.
    Hiniker SM; Knox SJ
    Semin Oncol; 2014 Dec; 41(6):702-13. PubMed ID: 25499631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation in cancer.
    Hegmans JP; Aerts JG
    Curr Opin Pharmacol; 2014 Aug; 17():17-21. PubMed ID: 25011112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing dendritic cells in cancer.
    Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
    Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience.
    Murray S; Lundqvist A
    Hum Vaccin Immunother; 2016 Mar; 12(3):607-11. PubMed ID: 26402368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hypoxia on immune state in cancer.
    Mortezaee K; Majidpoor J
    Life Sci; 2021 Dec; 286():120057. PubMed ID: 34662552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.
    Gajewski TF; Woo SR; Zha Y; Spaapen R; Zheng Y; Corrales L; Spranger S
    Curr Opin Immunol; 2013 Apr; 25(2):268-76. PubMed ID: 23579075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
    Fukumura D; Kloepper J; Amoozgar Z; Duda DG; Jain RK
    Nat Rev Clin Oncol; 2018 May; 15(5):325-340. PubMed ID: 29508855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment: a mechanical force link.
    Huang B
    Sci China Life Sci; 2015 Feb; 58(2):202-4. PubMed ID: 25563980
    [No Abstract]   [Full Text] [Related]  

  • 17. [Strategical consideration of the interaction between tumor microenvironment and tumor immunity].
    Fujiwara H
    Rinsho Ketsueki; 2018; 59(10):1895-1904. PubMed ID: 30305490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumor cells and tumor microenvironment on NK-cell function.
    Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
    Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the tumor microenvironment in the therapeutic management of cancer.
    Pottier C; Wheatherspoon A; Roncarati P; Longuespée R; Herfs M; Duray A; Delvenne P; Quatresooz P
    Expert Rev Anticancer Ther; 2015; 15(8):943-54. PubMed ID: 26098949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.